Flora Growth Corp. (FLGC)
USD 0.46
(0.62%)
USD 0.46
(0.62%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 10.57 Million USD | -73.47% |
| 2022 | 39.87 Million USD | 86.56% |
| 2021 | 21.37 Million USD | 71.47% |
| 2020 | 12.46 Million USD | 346.39% |
| 2019 | 2.79 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 3.41 Million USD | 46.71% |
| 2024 Q1 | 2.32 Million USD | -24.86% |
| 2023 Q1 | 8.52 Million USD | -8.1% |
| 2023 FY | 10.57 Million USD | -73.47% |
| 2023 Q4 | 3.09 Million USD | -43.65% |
| 2023 Q3 | 5.49 Million USD | -39.35% |
| 2023 Q2 | 9.06 Million USD | 6.3% |
| 2022 Q2 | 10.92 Million USD | 5.74% |
| 2022 FY | 39.87 Million USD | 86.56% |
| 2022 Q1 | 10.33 Million USD | 6.56% |
| 2022 Q4 | 9.27 Million USD | -0.77% |
| 2022 Q3 | 9.34 Million USD | -14.43% |
| 2021 FY | 21.37 Million USD | 71.47% |
| 2021 Q1 | 3.04 Million USD | -48.62% |
| 2021 Q4 | 9.69 Million USD | 129.14% |
| 2021 Q3 | 4.23 Million USD | 25.14% |
| 2021 Q2 | 3.38 Million USD | 11.11% |
| 2020 Q3 | 5.92 Million USD | 227.92% |
| 2020 Q2 | 1.8 Million USD | 198.99% |
| 2020 FY | 12.46 Million USD | 346.39% |
| 2020 Q1 | 604.11 Thousand USD | 0.0% |
| 2020 Q4 | 5.92 Million USD | 0.0% |
| 2019 Q2 | 1.89 Million USD | 0.0% |
| 2019 FY | 2.79 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bright Green Corporation | 8.25 Million USD | -28.186% |
| Alpha Teknova, Inc. | 45.85 Million USD | 76.931% |
| ANI Pharmaceuticals, Inc. | 195.98 Million USD | 94.602% |
| Aquestive Therapeutics, Inc. | 44.85 Million USD | 76.415% |
| Collegium Pharmaceutical, Inc. | 159.2 Million USD | 93.355% |
| Cosmos Health Inc. | 26.18 Million USD | 59.593% |
| Journey Medical Corporation | 54.59 Million USD | 80.622% |
| Embecta Corp. | 528.4 Million USD | 97.998% |
| Esperion Therapeutics, Inc. | 271.89 Million USD | 96.109% |
| Dynavax Technologies Corporation | 219.14 Million USD | 95.173% |
| Intra-Cellular Therapies, Inc. | 590 Million USD | 98.207% |
| Pacira BioSciences, Inc. | 326.37 Million USD | 96.759% |
| PainReform Ltd. | 9.58 Million USD | -10.382% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | 19.395% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | 19.395% |
| SCYNEXIS, Inc. | 51.84 Million USD | 79.596% |
| Safety Shot Inc | 12.1 Million USD | 12.64% |
| China SXT Pharmaceuticals, Inc. | 3.06 Million USD | -244.684% |
| Procaps Group, S.A. | 199.47 Million USD | 94.697% |
| Theratechnologies Inc. | 72.75 Million USD | 85.46% |
| Harrow Health, Inc. | 89.97 Million USD | 88.242% |
| Sonoma Pharmaceuticals, Inc. | 9.44 Million USD | -11.994% |
| Biofrontera Inc. | 39.95 Million USD | 73.525% |
| DURECT Corporation | 43.71 Million USD | 75.8% |
| Supernus Pharmaceuticals, Inc. | 529.01 Million USD | 98.0% |
| Cronos Group Inc. | 96.7 Million USD | 89.061% |
| OptiNose, Inc. | 85.1 Million USD | 87.569% |
| Ironwood Pharmaceuticals, Inc. | 232.12 Million USD | 95.443% |
| Kala Pharmaceuticals, Inc. | 39.15 Million USD | 72.98% |
| RedHill Biopharma Ltd. | -9.56 Million USD | 210.647% |
| Organogenesis Holdings Inc. | 314.13 Million USD | 96.632% |
| Guardion Health Sciences, Inc. | 9.73 Million USD | -8.716% |
| Cumberland Pharmaceuticals Inc. | 43.04 Million USD | 75.421% |
| Radius Health, Inc. | 265.92 Million USD | 96.022% |
| Universe Pharmaceuticals INC | 13.84 Million USD | 23.573% |
| ProPhase Labs, Inc. | 37.85 Million USD | 72.052% |
| Phibro Animal Health Corporation | 260.29 Million USD | 95.936% |
| Procaps Group S.A. | 187.24 Million USD | 94.35% |
| Alvotech | 285.43 Million USD | 96.294% |
| TherapeuticsMD, Inc. | 9.82 Million USD | -7.674% |
| Viatris Inc. | 5.96 Billion USD | 99.823% |
| Rockwell Medical, Inc. | 15.37 Million USD | 31.189% |
| Aytu BioPharma, Inc. | 59.84 Million USD | 82.321% |
| SIGA Technologies, Inc. | 22.04 Million USD | 52.007% |
| Tilray Brands, Inc. | 251.35 Million USD | 95.791% |
| Lifecore Biomedical, Inc. | 49.03 Million USD | 78.427% |
| Shineco, Inc. | 17.94 Million USD | 41.058% |
| PetIQ, Inc. | 192.72 Million USD | 94.511% |
| Regencell Bioscience Holdings Limited | 3.99 Million USD | -165.062% |
| Incannex Healthcare Limited | 30.05 Million USD | 64.799% |
| Neurocrine Biosciences, Inc. | 1.59 Billion USD | 99.337% |
| Alimera Sciences, Inc. | 62.64 Million USD | 83.112% |
| Silver Spike Investment Corp. | 762.49 Thousand USD | -1287.424% |
| Assertio Holdings, Inc. | 368.58 Million USD | 97.13% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.88 Million USD | -79.745% |
| Petros Pharmaceuticals, Inc. | 17.8 Million USD | 40.596% |
| Clever Leaves Holdings Inc. | 21.16 Million USD | 50.026% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | 49.725% |
| Avadel Pharmaceuticals plc | 164.96 Million USD | 93.587% |
| Hempacco Co., Inc. | 7.59 Million USD | -39.262% |
| Talphera, Inc. | 11.99 Million USD | 11.798% |
| Alvotech | 285.43 Million USD | 96.294% |
| Eagle Pharmaceuticals, Inc. | 140.71 Million USD | 92.482% |
| Lantheus Holdings, Inc. | 344.9 Million USD | 96.933% |
| Currenc Group, Inc. | 24 Million USD | 55.925% |
| Kamada Ltd. | 45.42 Million USD | 76.712% |
| Indivior PLC | 911 Million USD | 98.839% |
| Evoke Pharma, Inc. | 12.4 Million USD | 14.752% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | 49.725% |
| Evolus, Inc. | 189.75 Million USD | 94.425% |
| HUTCHMED (China) Limited | 436.23 Million USD | 97.575% |
| Amphastar Pharmaceuticals, Inc. | 154.13 Million USD | 93.136% |
| Akanda Corp. | 3.48 Million USD | -203.688% |